Loo, Li Shen
Plato, Brian M.
Turner, Ira M.
Case, Michael G.
Raskin, Joel
Dowsett, Sherie A.
Krege, John H.
Funding for this research was provided by:
Eli Lilly and Company (The SPARTAN and SAMURAI studies were sponsored by CoLucid Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company.)
Article History
Received: 19 April 2019
Accepted: 30 July 2019
First Online: 13 August 2019
Ethics approval and consent to participate
: The SAMURAI and SPARTAN studies were conducted in accordance with the International Conference on Harmonization Good Clinical Practice guideline, and local regulatory requirements. The study protocols were approved by an independent ethics committee or institutional review board at each study site. All patients provided written informed consent for study participation prior to the start of the study.
: Not applicable.
: LSL, MGC, RJ, SAD and JHK are full time employees and minor stockholders at Eli Lilly and Company.BMP reports no competing interests.IMT has served as investigator, as consultant, as speaker and on advisory boards of companies manufacturing branded migraine products.